In vitro antibacterial activity of tigecycline against multidrug-resistant bacteria isolated at the Sourô Sanou University teaching hospital in Bobo-Dioulasso, Burkina Faso
This was the first report on the evaluation of tigecycline activity on MDRBs in Burkina Faso. This non-marketed antibiotic in Burkina Faso could represent an alternative to spare carbapenems in the treatment of ESBL-E infections, and a last resort antibiotic against susceptible CRS infections in Burkina Faso's hospitals.
Institutions
- Inserm (FR)
- Nazi Boni University (BF)
- Institute for Neurosciences of Montpellier (FR)
- West African Health Organisation (BF)
- Centre Muraz (BF)
Publication Details
- Journal
- African Journal of Laboratory Medicine
- Published
- 2025-12-18
- DOI
- https://doi.org/10.4102/ajlm.v14i1.2895
- Primary Topic
- Antibiotic Resistance in Bacteria
- Type
- article
- Field-Weighted Citation Impact
- 0.00